Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Pipeline advancements and asset acquisitions fuelled mid-cap biotech R&D spend in 2014

Combined R&D spend of 35 mid-cap biotech companies increased by nearly US$2bn to reach a total of $9.7bn in 2014

R and D | Biotechnology | Finance

SciFluor raises US$30m in funding to move fluorine-based treatments into clinical development

The company recently received two US patents for potential treatments for retinal and neurological diseases

North America | R and D | Finance

New NCEs focus on cancer and orphan diseases

The number of NCEs approved in Europe increased again in 2014, with the spotlight on cancer drugs and treatments for unmet medical needs. Dr Sarah Houlton reviews the new entrants

Regulatory | R and D

Hosokawa offers new Mini Cyclomix for blending DPI formulations

The versatile product has many key features that add benefits to the development of pharmaceutical powders

Europe | Manufacturing and Equipment

SGS Life Science Services completes expansion and investment programme at facility in Mumbai, India

Doubles laboratory space and increases workforce from 65 to 115 people

Regulatory | Asia

Schott prepares for the launch of adaptiQ ready-to-use vials

Since the adaptiQ ready-to-use-pharmaceutical vial concept was launched at CPhI in 2014, Schott has seen strong interest from its customers and positive feedback from the market, and is now ramping up production ready for commercial launch early in 2015

Packaging | Manufacturing and Equipment

Biologics safety testing market to be worth US$3.13bn by 2019, forecasts report

Growth of the pharma and biotech industries and an increasing number of new biologics products are driving growth

Europe | Biotechnology | Measurement and Analysis

Paediatric research network takes shape

An international resource to develop expert networks for paediatric medicines using scarce available specialists is making progress thanks to initiatives on both sides of the Atlantic

Regulatory | R and D | Baby and Children

Recipharm starts negotiations with LIDDS on large-scale manufacture of Liproca Depot

Potential in LIDDS’ technology platform for development of new treatments for diseases where local administration is desirable


New assembly lines for drugs using continuous flow concepts

New technologies in the production of both small molecules and biological drugs are helping companies move towards continuous processes but the challenges are still significant. Susan Birks reports on recent process developments

Manufacturing and Equipment

BioReliance licenses B-CLEAR technology from Qualyst Transporter Solutions

The first technology of its kind to enable measuring of physiologic intracellular concentrations

North America | R and D | Biotechnology

Selecting stoppers for use in the lyophilisation of moisture-sensitive drugs

When considering the lyophilisation of moisture-sensitive biopharmaceuticals, companies must not only consider the moisture transfer via the container but also the stopper, as Dr Heike Kofler, West Pharmaceutical Services, explains

Packaging | Manufacturing and Equipment